Please login to the form below
Biogen
This page shows the latest Biogen news and features for those working in and with pharma, biotech and healthcare.
Novartis buys gene therapy firm AveXis for $8.7bn
Last year, Biogen secured approval for the first drug treatment for SMA, a progressive, debilitating muscle-wasting disease that affects about 23, 500 patients worldwide.
Latest news
-
Settlement clears path for Biogen, Samsung’s Humira biosimilar
Settlement clears path for Biogen, Samsung’ s Humira biosimilar. Agreement could see Europe access Imraldi as early as October this year. ... Biogen and partner Samsung Bioepis have agreed a deal that will allow their biosimilar version of AbbVie’s
-
Biogen pays $590m for Pfizer cognition drug
Biogen pays $590m for Pfizer cognition drug. Early stage studies look positive for schizophrenia drug. ... When cognition is impaired, you lose the ability to make sense of the world, ”said Michael Ehlers, Biogen’s head of R&D.
-
Biogen and AbbVie pull MS drug Zinbryta from the market
Biogen and AbbVie pull MS drug Zinbryta from the market. Potential risks of liver damage and immune-related conditions have been reported. ... Biogen and AbbVie have voluntarily withdrawn their multiple sclerosis drug Zinbryta from the market worldwide,
-
FDA turns down Celgene’s filing for multiple sclerosis drug
The efficacy of the drug had been demonstrated by two phase III trials comparing it to Biogen’s injectable interferon beta therapy Avonex, said Alles, who said the company “remains
-
AZ adds another Ionis drug in $330m kidney disease deal
After many years at the forefront of efforts to develop antisense drugs, Ionis’pipeline has started to deliver with Biogen-partnered Spinraza (nusinersen) on the market for spinal muscular atrophy and
More from news
Approximately 93 fully matching, plus 258 partially matching documents found.
Latest Intelligence
-
No incentive for a cure
to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.
-
Deal Watch January 2018
Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... Option, licence. 223. Karyopharm Therapeutics/ Biogen. Oral SINE compound
-
The good, the bad and the ugly
Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue, ”says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Biogen also has Aducanumab in the pipeline, which is forecast to generate huge sales
-
Simplifying HCP access to digital information
Biogen, one of Align Biopharma’s founding members. ... Other founding members include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis and Pfizer.
-
Managing medication non-adherence
efficacious. Biogen has been playing in this space for a few years now and conducted a clinical trial with PatientsLikeMe that showed how people living with multiple sclerosis (MS) can use
More from intelligence
Approximately 1 fully matching, plus 31 partially matching documents found.
Latest appointments
-
Editas Medicine names James Mullen as chairman
Before joining Patheon, Mullen served as chief executive officer and president at Biogen and before this he held numerous roles at the biotech.
-
Acumen appoints new strategy director
Thomas Bols will focus on reinforcing Acumen’s healthcare practice
-
Biogen appoints Jeff Capello as executive VP and CFO
Biogen appoints Jeff Capello as executive VP and CFO. He will lead the company's business and finance planning functions. ... Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.
-
Constellation Pharmaceuticals appoints Emma Reeve as CFO
Prior to that he spent ten years at Cubist Pharmaceuticals, Biogen and Covance.
-
US biotech Translate Bio appoints Daniella Beckman
She has also held various finance positions at Coley Pharmaceuticals - which was acquired by Pfizer in 2008 - and Biogen Idec.
More from appointments
Approximately 15 fully matching, plus 30 partially matching documents found.
Latest from PMHub
-
Pegasus shortlisted for four PM Society Digital Media Awards 2016
four awards at the PM Society Digital Media Awards 2016 for its ‘ MS Explorer’ exhibit stand installation for Biogen, and 'Beatbox Cough' campaign for Boehringer Ingelheim and the Roy Castle Lung ... As a leader in multiple sclerosis (MS) treatment,
-
It’s a digital hat trick for Pegasus as it scoops GOLD and two SILVERS at the PM Society Digital Awards 2016
Pegasus received three top accolades at the PM Society Digital Media Awards 2016, including gold for the highly acclaimed Craft: Best Innovation award with Biogen’ s MS Explorer, and two silvers ... As a leader in multiple sclerosis (MS) treatment,
-
It's time to change the conversation
This is due in a large part to Biogen’ s approach and leadership in the treatment of the disease. ... to patient information.Biogen changed the conversation about the disease as well as the conversation with patients.
-
Wallace Health
Our expertise spans healthcare providers, pharmaceuticals and consumer health and we work for clients including HCA Hospitals, Alliance Medical, GSK and Biogen as well as high-performing start-ups such as
-
Bedrock Healthcare Communications
Abbvie. Baxalta. Baxter. Biogen. BMS. Britannia. CareFusion. Celgene. Ipsen. Janssen. Novartis.
More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.
Featured jobs
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Medical Writer
-
Great salary and bebefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager / Account Director
-
Great salary and bebefits
Subscribe to our email news alerts
- Shire warms to Takeda’s latest offer, extending deadline
- Otsuka finally gets FDA OK for kidney disease drug
- Pfizer takes aim at UK’s health tech industry
- Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more
- It’s nice, but it’s not an infographic
- PureTech Health appoints new chief financial officer
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
